The Forum for Collaborative HIV Research - 14th Intn'l Workshop on Co-morbidities & Adverse Drug Reactions in HIV

In This Section

Announcements

On Behalf of IDSA: Urge Lawmakers to Protect PEPFAR Funding

MAY-22-13 IDSA is asking for you to join them and lend your name to a letter in support of PEPFAR funding for the next fiscal year. Click here to read the letter and sign by Monday, June 3-Noon Eastern time.

Renewal of the National Viral Hepatitis Action Plan, 2014-2016

MAY-20-13 Dr. Ronald Valdiserri writes to recognize the second anniversary of Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis and to share an important announcement from Dr. Howard Koh about plans to update and renew the existing plan through 2014-2016.

HIV Forum congrulates Nina Mani on her new position at FDA

MAY-17-13 Please join the Forum in congratulating Nina Mani on an exciting new career move. Nina is leaving the Forum, but she is not going far – starting June 3 she will join the FDA Center for Drug Evaluation Research, Division of Antiviral Products. That we will miss her is the understatement of the century. But the offer to join our colleagues at the FDA as a project manager presented a phenomenal opportunity – an excellent fit for her career path. We congratulate Jeff, Kim, Jules and Patrick on an excellent choice! We imagine that many of you will have the pleasure of interacting with her in her new capacity.

National Viral Hepatitis Action Plan to Be Renewed

MAY-16-13 Dr. Howard Koh, the Assistant Secretary for Health, announced on May 16 that the partner agencies are committed and dedicated to renewing the Action Plan for another three years and are currently working on their vision and priorities for 2014-2016.

HIV Forum Mourns the Passing of Executive Committee Member Dr. Jim Goodrich

MAY-10-13 We are saddened to report the death of James Goodrich, PhD, MD of ViiV Healthcare, a member of the Forum’s Executive Committee. Jim passed away unexpectedly last weekend and is survived by his wife, Carolyn and two teenage daughters. A memorial service for Jim will be held this summer on a date to be determined. Jim has been a considered and thoughtful participant on the Executive Committee. His desire to improve care for patients, direct approach and sense of humor will be missed. Please join us in keeping Jim’s family in our thoughts and prayers.

Upcoming Events

29-Jun-13

IAS 2013 Towards an HIV Cure Symposium

14-Jun-13

FDA Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research

04-Jun-13

International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies

23-May-13

Hepatitis B and C Testing and Awareness Day in House of Representatives

Join Our Email Service

14th Intn'l Workshop on Co-morbidities & Adverse Drug Reactions in HIV

FEB-22-12 Following the success of previous years, International Medical Press (IMP) is pleased to announce the 14th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV. The 2012 Workshop will take place July 19-21, 2012 in Washington D.C., USA. It will consist of a combination of plenary sessions, presentations and poster sessions displaying the most current research in the field of metabolic complications, lipodystrophy, co-morbidities and related topics in HIV. The programme this year includes many distinguished plenary speakers covering an extensive range of topics. Click here to view the agenda.

Registration and abstract submission is now open

REGISTRATION: The deadline for Early Bird Registration is March 9, 2012. Click here to register, and for additional information.

ABSTRACTS: Accepted abstracts will selected for either Oral or Poster presentation, at the discretion of the Organizing Committee. All accepted abstracts for the 14th Workshop will be published in the peer-reviewed journal, Antiviral Therapy. Presenters of accepted abstracts are required to register for the Workshop.

The deadline is May 25, 2012. Click here for more information on abstract submission.